Susan M. Poppe

Novel 1,5-Diphenylpyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine-Resistant P236L Mutant:  Lead Identification and SAR of 3- and 4-Substituted Derivatives

Michaël Génin, Carolyn Biles, Barb J. Keiser et al. · Journal of Medicinal Chemistry · 2000 · 375 citations · Full text

Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.

Donna L. Romero, M. Busso, Cheng Keat Tan et al. · Proceedings of the National Academy of Sciences · 1991 · 242 citations · Full text

Immunology, Molecular Biology, Antiviral Drug +16

Fresh visceral examination of rat and rabbit fetuses used in teratogenicity testing

J. L. Stuckhardt, Susan M. Poppe · Teratogenesis Carcinogenesis and Mutagenesis · 1984 · 213 citations

Fetal Medicine, Fresh Visceral Examination, Pathology +19

In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains

Karen Joy Shaw, Susan M. Poppe, Ronda D. Schaadt et al. · Antimicrobial Agents and Chemotherapy · 2008 · 179 citations · Full text

Antimicrobial Chemotherapy, Vitro Sensitivity, Antibiotic Resistance +18

A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.

T J Dueweke, T Pushkarskaya, Susan M. Poppe et al. · Proceedings of the National Academy of Sciences · 1993 · 163 citations · Full text

Hiv-1 Resistance, Immunology, Other Nonnucleoside Inhibitors +19